@@ 1文献类型rn治疗.rn2证据水平rn2b.rn3文献来源rnBuzdar AU, Ibrahim NK, Francis D, et al.Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab,paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer [J]. J Clin Oncol, 2005,23 (16): 3676-3685.
展开▼
